MedTrace Logo

Remote Monitoring in Diabetes Disease Management

NCT00675311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2009-12-18

No results posted yet for this study

Summary

The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.

Conditions

Interventions

BEHAVIORAL

DM-Standard

Device/t+ Medical Diabetes Management System

BEHAVIORAL

Disease Management Plus

Plus is one of the randomized arms of the study. Patients assigned to this arm receive support from Disease Management nurses and technology.

Sponsors & Collaborators

  • LifeScan

    lead INDUSTRY

Principal Investigators

  • Donald Fetterolf, MD · Matria Healthcare

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00675311 on ClinicalTrials.gov